STOCK TITAN
  1. Home
  2. News
  3. BDX

Becton Dickinson & Co. - BDX STOCK NEWS

Welcome to our dedicated news page for Becton Dickinson & Co. (Ticker: BDX), a resource for investors and traders seeking the latest updates and insights on Becton Dickinson & Co..

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Becton Dickinson & Co.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Becton Dickinson & Co.'s position in the market.

News
BD Announces Webcast of Annual Meeting of Shareholders
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) to host live webcast of Annual Meeting of Shareholders on January 23, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
BD to Announce Financial Results for its First Quarter of Fiscal 2024
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) will report financial results for its first quarter of fiscal year 2024 on February 1, 2024. The news release will include summary financial information for the period ending on December 31, 2023. BD management will host an audio webcast to discuss financial results and provide an update on its operations and strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
earnings
-
News
BD to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) to present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
conferences
News
BD Signs World Economic Forum's Zero Health Gaps Pledge
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) reinforces its commitment to improve health equity and expand access to care among vulnerable populations by signing the World Economic Forum's Zero Health Gaps Pledge. The company aims to accelerate progress toward equity and drive positive health outcomes by embedding health equity principles across company strategy and social investments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
none
-
News
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) receives 510(k) clearances from the U.S. FDA for the BD MiniDraw™ Capillary Blood Collection System, enabling lab-quality blood testing from less invasive fingerstick method for common blood tests. The system expands access to blood collection in convenient locations like retail pharmacies, providing a better patient experience and potential to transform diagnostic testing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
clinical trial
-
News
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) will present the next installment of its BD Innovates series, highlighting its Pharmaceutical Systems business on December 11, 2023, at 11:30 am Eastern Time. The series showcases BD's innovation, products, and pipeline in support of its BD 2025 Strategy. The live webcast can be accessed from the BD investor relations website, investors.bd.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
conferences
News
FDA Safety Communication Does Not Impact BD Syringes
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) reaffirms its commitment to supporting the U.S. health care system by addressing the U.S. Food and Drug Administration (FDA) Safety Communication on plastic syringes. BD president Eric Borin assures that the safety notice does not apply to any BD syringes, emphasizing that all plastic syringes provided to the U.S. health care system are manufactured in the United States. BD is prepared to increase production to aid providers affected by the FDA communication. With a history dating back to 1897, BD has consistently supported health care needs, including during world wars, vaccination trials, and pandemics, such as manufacturing 2 billion additional syringes for COVID-19 vaccinations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
-
News
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) has launched the SiteRite™ 9 Ultrasound System, designed to improve clinician efficiency in placing vascular access devices. The system features enhanced image quality, vessel assessment tools, and integrated visualization tools to aid in first attempt IV insertion success. It also includes smart, connected technology and patient data look up capabilities, aligning with BD's commitment to advancing the standard of care for patients and health care providers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
none
-
News
BD Names Dr. Ronald Silverman as Chief Medical Officer
Rhea-AI Summary
BD (Becton, Dickinson and Company) (BDX) appoints Dr. Ronald Silverman as executive vice president and chief medical officer, effective Dec. 4, 2023. Dr. Silverman will lead BD's Medical Affairs organization, focusing on innovative solutions and patient safety. He replaces Dr. William Sigmund, who announced his retirement in June 2023. Dr. Silverman brings nearly 30 years of experience in clinical practice, academic research, and industry roles, previously serving as senior vice president and chief medical officer at 3M Health Care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.07%
Tags
none
News
BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) to Present at 6th Annual Evercore ISI HealthCONx Conference on November 28, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
conferences
Stock BDX logo
Becton Dickinson & Co.

NYSE:BDX

BDX Rankings

#180 Ranked by Market Cap
#1535 Ranked by Stock Gains
#1555 Ranked by Dividends

BDX Stock Data

66.74B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Franklin Lakes

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.